WNK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Among them, brassinin induces three distinct forms of cell death—apoptosis, autophagy, and paraptosis—in chronic myelogenous leukemia (CML) cells through the activation of the mitogen-activated protein kinase (MAPK) signaling pathway [39].